Effect of hypoalbuminemia on drug pharmacokinetics
Frontiers in Pharmacology · 20.02.2025 · 16
DOI: 10.3389/fphar.2025.1546465 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.02.2025. Verfasst von Ilona Idasiak-Piechocka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Transplant Surgery, Poznan University of Medical Sciences, Poznan, Poland. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypoalbuminemia, defined as serum albumin levels below 35 g/L, is common in patients with conditions such as nephrotic syndrome, cirrhosis, or sepsis. This review examines the impact of hypoalbuminemia on the pharmacokinetics of selected drugs—such as antibiotics, immunosuppressants, antifungals, or anticonvulsants—emphasizing its role in drug efficacy and safety. Albumin is the main drug transporter and key binding protein, which influences the free drug concentration and drug activity. The review includes all studies available in the scientific literature found in the PubMed, Scopus, and Cochrane databases. The paper emphasizes the importance of therapeutic drug monitoring (TDM) in patients with hypoalbuminemia to avoid subtherapeutic or toxic drug levels. Many drugs need for dose adjustments to achieve therapeutic levels, especially in critically ill patients. The results of studies emphasize the need for individualized dosing regimens based on TDM to optimize drug therapy in patients with hypoalbuminemia. Our review is the first article to summarize the influence of hypoalbuminemia on the pharmacokinetic parameters of drugs and may be a useful tool for clinicians in their daily work.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General and Transplant Surgery, Poznan University of Medical Sciences, Poznan, Poland.
- The Student Scientific Society of Poznan University of Medical Sciences, Poznan, Poland.
- Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland.
Zitieren
APA
Idasiak-Piechocka, I., Lewandowski, D., Świgut, W., Kalinowski, J., Mikosza, K., Suchowiejski, P., Szałek, E., Karbownik, A., & Miedziaszczyk, M. (2025). Effect of hypoalbuminemia on drug pharmacokinetics. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1546465
Vancouver
Idasiak-Piechocka I, Lewandowski D, Świgut W, Kalinowski J, Mikosza K, Suchowiejski P, et al. Effect of hypoalbuminemia on drug pharmacokinetics. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1546465
BibTeX
@article{IdasiakPiechocka2025,
author = {Idasiak-Piechocka, Ilona and Lewandowski, Dominik and Świgut, Wojciech and Kalinowski, Jan and Mikosza, Klaudia and Suchowiejski, Piotr and Szałek, Edyta and Karbownik, Agnieszka and Miedziaszczyk, Miłosz},
title = {Effect of hypoalbuminemia on drug pharmacokinetics},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1546465}
}
EUVIMED